InternationalUSRemember you can easily switch between MIP US and MIP International at any time

In-house roundup: anti-anti-suit injunction filers reveal insights; US-UK trade documents unpacked; open source case spurs NPE fear



06 December 2019   |  

Patrick Wingrove, London


Managing IP rounds up the latest news and analysis from patent-focused businesses

Money

Anti-anti-suit injunctions: filers reveal importance of new orders 

IPCom, Nokia and two car companies say the success of the new order shows that forum-shopping does not fly with European courts and – if that continues – anti-suit injunctions will not become popular as a ‘stalling tool’. Read more... 

What the US-UK trade deal documents actually reveal 

Generics and innovator sources from the pharma industry explain why documents from US and UK trade discussions do not point to the US trying to extend pharmaceutical patents. Read more... 

Open source case prompts patent troll litigation fears 

Software stakeholders including the Linux Foundation, Qualcomm and Unified Patents are concerned that RPI v Gnome has opened the door to open source NPE litigation. Read more... 

Dismantling the patent system not a 'silver bullet' to lower drug prices 

In-house counsel from pharma innovators say the IP system is unfairly under attack for rising drug prices and that new drugs will not reach the market without patents. Read more... 

Comments






More from the Managing IP blog


null null null

null null null


November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing



Most read articles

Supplements

Change font size: Switch to default font size Switch to medium font size Switch to large font size
Back to top

The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms and Conditions and Privacy Policy before using the site. All material subject to strictly enforced copyright laws. © 2020 Euromoney Institutional Investor PLC. For help please see our FAQ.

v 1.0.144

Switching to MIP International